Compound Detail
CHEMBL219507
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL219507 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QJPOKLYNFHIKGR-ONEGZZNKSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
250.3
MW (Da)
3.45
ALogP
3
HBA
1
HBD
56.9
PSA (Ų)
0.89
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Molecular identity unknown CHEMBL612546 | IC50 | 6.1 | 6.1 | 794.3 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Molecular identity unknown | IC50 | = | 794.33 | nM | 6.1 | Inhibition of c-RAF1/MEK1/ERK2 signalling pathway by SPA | 16890436 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16890436 | 10.1016/j.bmcl.2006.07.063 | Molecular identity unknown | 1 |
Data from ChEMBL 36 via Core Engine